Vesicare and Tooth impacted - a phase IV clinical study of FDA data

Summary:

Tooth impacted is reported as a side effect among people who take Vesicare (solifenacin succinate), especially for people who are male, 50-59 old, also take Zometa, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Tooth impacted when taking Vesicare. It is created by eHealthMe based on reports of 29,875 people who have side effects when taking Vesicare from the FDA, and is updated regularly.

What is Vesicare?

Vesicare has active ingredients of solifenacin succinate. It is often used in urge incontinence. eHealthMe is studying from 30,655 Vesicare users. Check the latest studies of Vesicare.

What is Tooth impacted?

Tooth impacted (a tooth that fails to fully pass through the gums) is found to be associated with 260 drugs and 195 conditions by eHealthMe. Check the latest studies of Tooth impacted.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

29,875 people reported to have side effects when taking Vesicare.
Among them, 23 people (0.08%) have Tooth impacted.

Among these 23 people:

What is the gender of people who have Tooth impacted when taking Vesicare? *

female: 34.78 %
male: 65.22 %

What is the age of people who have Tooth impacted when taking Vesicare? *

What are other drugs people take besides Vesicare? *

What are other side effects people have besides Tooth impacted? *

Bone Disorder: 23 people, 100.00%
Osteomyelitis (infection of bone): 23 people, 100.00%
Rashes (redness): 22 people, 95.65%
Fever: 22 people, 95.65%
Sinusitis (inflammation of sinus): 22 people, 95.65%
Haemorrhoids (a swollen vein or group of veins in the region of the anus): 22 people, 95.65%
Headache (pain in head): 22 people, 95.65%
Pain In Jaw: 22 people, 95.65%
Tooth Abscess (pus formation in tooth): 22 people, 95.65%
Upper Respiratory Tract Infection: 22 people, 95.65%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 16 people, 69.57%
Depression: 7 people, 30.43%
Stress And Anxiety: 6 people, 26.09%
Sleep Disorder: 6 people, 26.09%
Neoplasm Malignant (cancer tumour): 6 people, 26.09%
Metastases To Bone (cancer spreads to bone): 6 people, 26.09%
Breast Cancer Metastatic: 6 people, 26.09%
Toothaches (tooth pain): 1 person, 4.35%
Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 1 person, 4.35%
Pain: 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Vesicare and have Tooth impacted?

- Check whether Tooth impacted is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Vesicare:

Vesicare (30,655 reports)

Browse all side effects of Vesicare:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Tooth impacted:

Tooth impacted (260 drugs)

Browse all the conditions that are associated with Tooth impacted:

Tooth impacted (195 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on solifenacin succinate (the active ingredients of Vesicare) and Vesicare (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.